DRLIX | MGLCX | DRLIX / MGLCX | |
Total Expense Ratio | 1.05 | 1.94 | 54% |
Annual Report Gross Expense Ratio | 1.15 | 1.95 | 59% |
Fund Existence | 18 years | 10 years | - |
Gain YTD | 5.963 | 2.174 | 274% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 1000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 303M | 2.29B | 13% |
Annual Yield % from dividends | 2.63 | 1.30 | 202% |
Returns for 1 year | 13.69 | 3.22 | 426% |
Returns for 3 years | 10.43 | -1.71 | -608% |
Returns for 5 years | 21.25 | 9.29 | 229% |
Returns for 10 years | 16.82 | 8.31 | 202% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PVETX | 16.87 | N/A | N/A |
PACE Small/Medium Co Val Eq P2 | |||
JAGLX | 66.30 | -0.42 | -0.63% |
Janus Henderson Global Life Sciences T | |||
EVSIX | 24.26 | -0.27 | -1.10% |
Allspring Disciplined US Core Inst | |||
SLLAX | 12.28 | -0.22 | -1.76% |
SEI Small Cap F (SIMT) | |||
NESIX | 17.77 | -0.60 | -3.27% |
Needham Small Cap Growth Institutional |